AMY LINGENFELTER: Open Payments
NPI 1295048932 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,270 in 88 payments from 18 companies in 2025. Trend: 2023 $1,309 · 2024 $1,763 · 2025 $2,270
Food & beverage: $2,270
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $471 |
| AstraZeneca Pharmaceuticals LP | 10 | $331 |
| ARS Pharmaceuticals Operations, Inc. | 17 | $279 |
| CSL Behring | 9 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $184 |
| Novartis Pharmaceuticals Corporation | 6 | $169 |
| Grifols USA, LLC | 3 | $83 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Galderma Laboratories, L.P. | 4 | $68 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, Andembry, CUVITRU, FASENRA, Xembify, Rhapsido.
Industry payments across GA — which companies pay providers there.
